Texas Permanent School Fund trimmed its position in Balchem Co. (NASDAQ:BCPC – Get Rating) by 6.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,604 shares of the basic materials company’s stock after selling 1,502 shares during the quarter. Texas Permanent School Fund owned 0.07% of Balchem worth $2,638,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of BCPC. Vanguard Group Inc. raised its holdings in shares of Balchem by 7.3% in the 3rd quarter. Vanguard Group Inc. now owns 3,862,027 shares of the basic materials company’s stock worth $469,545,000 after purchasing an additional 261,534 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Balchem by 58.8% in the 3rd quarter. Price T Rowe Associates Inc. MD now owns 345,020 shares of the basic materials company’s stock worth $41,949,000 after purchasing an additional 127,686 shares during the period. Montanaro Asset Management Ltd raised its holdings in shares of Balchem by 227.4% in the 3rd quarter. Montanaro Asset Management Ltd now owns 155,500 shares of the basic materials company’s stock worth $18,906,000 after purchasing an additional 108,000 shares during the period. BlackRock Inc. raised its holdings in shares of Balchem by 1.7% in the 3rd quarter. BlackRock Inc. now owns 4,900,490 shares of the basic materials company’s stock worth $595,802,000 after purchasing an additional 83,220 shares during the period. Finally, Renaissance Technologies LLC raised its holdings in shares of Balchem by 32.4% in the 1st quarter. Renaissance Technologies LLC now owns 259,700 shares of the basic materials company’s stock worth $35,501,000 after purchasing an additional 63,500 shares during the period. 89.29% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Balchem news, Director David B. Fischer sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, March 20th. The stock was sold at an average price of $127.01, for a total value of $381,030.00. Following the transaction, the director now directly owns 17,269 shares of the company’s stock, valued at approximately $2,193,335.69. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Balchem news, Director David B. Fischer sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, March 20th. The stock was sold at an average price of $127.01, for a total value of $381,030.00. Following the transaction, the director now directly owns 17,269 shares of the company’s stock, valued at approximately $2,193,335.69. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Michael Robert Sestrick sold 2,300 shares of the company’s stock in a transaction that occurred on Tuesday, May 2nd. The shares were sold at an average price of $130.36, for a total value of $299,828.00. Following the completion of the transaction, the senior vice president now directly owns 5,424 shares in the company, valued at $707,072.64. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Balchem Stock Performance
Shares of NASDAQ:BCPC opened at $125.51 on Wednesday. The company has a market cap of $4.04 billion, a P/E ratio of 41.02 and a beta of 0.70. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.81 and a current ratio of 2.88. Balchem Co. has a one year low of $110.15 and a one year high of $143.88. The business’s 50-day simple moving average is $127.21 and its 200 day simple moving average is $130.51.
Balchem (NASDAQ:BCPC – Get Rating) last announced its earnings results on Friday, April 28th. The basic materials company reported $0.70 EPS for the quarter, missing the consensus estimate of $0.78 by ($0.08). The company had revenue of $232.54 million for the quarter, compared to analysts’ expectations of $232.00 million. Balchem had a net margin of 10.48% and a return on equity of 10.69%. During the same quarter in the previous year, the business posted $0.89 earnings per share. On average, sell-side analysts forecast that Balchem Co. will post 3.6 earnings per share for the current fiscal year.
Balchem Profile
Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems.
Featured Stories
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- How to Buy Southwest Airlines Stock
- Lucid Group Bottomed, But The Outlook Remains Cloudy
- Shoals Technology is an EV and Solar Play Just Getting Started
- Under Armour May Have Just Bottomed
- Skyworks Solutions: Another Crack in the Consumer Outlook
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC – Get Rating).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.
